
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4513546
[patent_doc_number] => 07931908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-26
[patent_title] => 'Chimeric MSP-based malaria vaccine'
[patent_app_type] => utility
[patent_app_number] => 12/070874
[patent_app_country] => US
[patent_app_date] => 2008-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 20704
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/931/07931908.pdf
[firstpage_image] =>[orig_patent_app_number] => 12070874
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/070874 | Chimeric MSP-based malaria vaccine | Feb 20, 2008 | Issued |
Array
(
[id] => 4872711
[patent_doc_number] => 20080199445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Compositions and methods for treatment of microbial infections'
[patent_app_type] => utility
[patent_app_number] => 12/069569
[patent_app_country] => US
[patent_app_date] => 2008-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9511
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199445.pdf
[firstpage_image] =>[orig_patent_app_number] => 12069569
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/069569 | Compositions and methods for treatment of microbial infections | Feb 10, 2008 | Issued |
Array
(
[id] => 6071224
[patent_doc_number] => 20110046075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Secreted Staphylococcus Aureus Proteins And Peptides For Use In Inhibiting Activation Of The Complement System'
[patent_app_type] => utility
[patent_app_number] => 12/526222
[patent_app_country] => US
[patent_app_date] => 2008-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15322
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046075.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526222
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526222 | Secreted Staphylococcus Aureus Proteins And Peptides For Use In Inhibiting Activation Of The Complement System | Feb 5, 2008 | Abandoned |
Array
(
[id] => 5315958
[patent_doc_number] => 20090280556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'Mesothelin, A Differentiation Antigen Present On Mesothelium, Mesotheliomas, and Ovarian Cancers and Methods and Kits for Targeting the Antigen'
[patent_app_type] => utility
[patent_app_number] => 12/021151
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18373
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12021151
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/021151 | Mesothelin, A Differentiation Antigen Present On Mesothelium, Mesotheliomas, and Ovarian Cancers and Methods and Kits for Targeting the Antigen | Jan 27, 2008 | Abandoned |
Array
(
[id] => 5585031
[patent_doc_number] => 20090104233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'IDENTIFICATION OF RESIDUES CRITICAL FOR THE FUNCTION OF THE VIBRIO CHOLERAE VIRULENCE REGULATOR ToxT BY SCANNING ALANINE MUTAGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/020398
[patent_app_country] => US
[patent_app_date] => 2008-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17335
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104233.pdf
[firstpage_image] =>[orig_patent_app_number] => 12020398
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/020398 | Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis | Jan 24, 2008 | Issued |
Array
(
[id] => 4823015
[patent_doc_number] => 20080227706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'BVH-A2 AND BVH-A3 ANTIGENS OF GROUP B STREPTOCOCCUS'
[patent_app_type] => utility
[patent_app_number] => 12/018071
[patent_app_country] => US
[patent_app_date] => 2008-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10123
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227706.pdf
[firstpage_image] =>[orig_patent_app_number] => 12018071
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/018071 | BVH-A2 AND BVH-A3 ANTIGENS OF GROUP B STREPTOCOCCUS | Jan 21, 2008 | Abandoned |
Array
(
[id] => 4675662
[patent_doc_number] => 20080213291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Malaria vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/006784
[patent_app_country] => US
[patent_app_date] => 2008-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12964
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213291.pdf
[firstpage_image] =>[orig_patent_app_number] => 12006784
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/006784 | Malaria vaccines | Jan 2, 2008 | Issued |
Array
(
[id] => 5374161
[patent_doc_number] => 20090311722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/965004
[patent_app_country] => US
[patent_app_date] => 2007-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10660
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311722.pdf
[firstpage_image] =>[orig_patent_app_number] => 11965004
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/965004 | Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains karp, kato and gilliam and its use in antibody based detection assays and vaccines | Dec 26, 2007 | Issued |
Array
(
[id] => 4839396
[patent_doc_number] => 20080279881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains karp, kato and gilliam and its use in antibody based detection assays and vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/964982
[patent_app_country] => US
[patent_app_date] => 2007-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11766
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20080279881.pdf
[firstpage_image] =>[orig_patent_app_number] => 11964982
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/964982 | Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines | Dec 26, 2007 | Issued |
Array
(
[id] => 5580566
[patent_doc_number] => 20090175912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Haemophilus Influenza Outer Membrane Protein and Use Thereof in Vaccination'
[patent_app_type] => utility
[patent_app_number] => 11/960883
[patent_app_country] => US
[patent_app_date] => 2007-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6572
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20090175912.pdf
[firstpage_image] =>[orig_patent_app_number] => 11960883
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/960883 | Haemophilus influenzae outer membrane protein and use thereof in vaccination | Dec 19, 2007 | Issued |
Array
(
[id] => 6302374
[patent_doc_number] => 20100068214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus'
[patent_app_type] => utility
[patent_app_number] => 12/520395
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23663
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12520395
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520395 | Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus | Dec 18, 2007 | Abandoned |
Array
(
[id] => 6423760
[patent_doc_number] => 20100168012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'HUMAN CANCER THERAPY USING ENGINEERED MATRIX METALLOPROTEINASE-ACTIVATED ANTHRAX LETHAL TOXIN THAT TARGETS TUMOR VASCULATUTURE'
[patent_app_type] => utility
[patent_app_number] => 12/519362
[patent_app_country] => US
[patent_app_date] => 2007-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23992
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168012.pdf
[firstpage_image] =>[orig_patent_app_number] => 12519362
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/519362 | HUMAN CANCER THERAPY USING ENGINEERED MATRIX METALLOPROTEINASE-ACTIVATED ANTHRAX LETHAL TOXIN THAT TARGETS TUMOR VASCULATUTURE | Dec 13, 2007 | Abandoned |
Array
(
[id] => 6439549
[patent_doc_number] => 20100279344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'Integrated cytokine production system'
[patent_app_type] => utility
[patent_app_number] => 12/000470
[patent_app_country] => US
[patent_app_date] => 2007-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8436
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279344.pdf
[firstpage_image] =>[orig_patent_app_number] => 12000470
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/000470 | Integrated cytokine production system | Dec 12, 2007 | Abandoned |
Array
(
[id] => 8066081
[patent_doc_number] => 20110243980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'METHODS AND SYSTEMS FOR O-GLYCOSYLATING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/519085
[patent_app_country] => US
[patent_app_date] => 2007-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9969
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20110243980.pdf
[firstpage_image] =>[orig_patent_app_number] => 12519085
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/519085 | Methods and systems for O-glycosylating proteins | Dec 12, 2007 | Issued |
Array
(
[id] => 5410073
[patent_doc_number] => 20090123972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Staphylococcal nuclease fusion proteins for the production of recombinant peptides'
[patent_app_type] => utility
[patent_app_number] => 12/000370
[patent_app_country] => US
[patent_app_date] => 2007-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14428
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123972.pdf
[firstpage_image] =>[orig_patent_app_number] => 12000370
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/000370 | Staphylococcal nuclease fusion proteins for the production of recombinant peptides | Dec 11, 2007 | Abandoned |
Array
(
[id] => 5415909
[patent_doc_number] => 20090041796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Surface protein of leptospira'
[patent_app_type] => utility
[patent_app_number] => 12/001114
[patent_app_country] => US
[patent_app_date] => 2007-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6926
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041796.pdf
[firstpage_image] =>[orig_patent_app_number] => 12001114
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/001114 | Surface protein of leptospira | Dec 9, 2007 | Issued |
Array
(
[id] => 11136605
[patent_doc_number] => 09372191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-21
[patent_title] => 'Methods and devices for detecting methicillin resistant Staphylococcus aureus'
[patent_app_type] => utility
[patent_app_number] => 12/517771
[patent_app_country] => US
[patent_app_date] => 2007-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2210
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12517771
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/517771 | Methods and devices for detecting methicillin resistant Staphylococcus aureus | Dec 9, 2007 | Issued |
Array
(
[id] => 6436658
[patent_doc_number] => 20100143936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Novel Specific Arabinose Transporter from the Yeast Pichia Stipitis, and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/520487
[patent_app_country] => US
[patent_app_date] => 2007-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9642
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143936.pdf
[firstpage_image] =>[orig_patent_app_number] => 12520487
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520487 | Specific arabinose transporter from the yeast Pichia stipitis, and uses thereof | Dec 6, 2007 | Issued |
Array
(
[id] => 4791661
[patent_doc_number] => 20080292634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Nontypable Haemophilus Infuenzae Virulence Factors'
[patent_app_type] => utility
[patent_app_number] => 11/946563
[patent_app_country] => US
[patent_app_date] => 2007-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13578
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20080292634.pdf
[firstpage_image] =>[orig_patent_app_number] => 11946563
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/946563 | Nontypeable Haemophilus influenzae virulence factors | Nov 27, 2007 | Issued |
Array
(
[id] => 7527033
[patent_doc_number] => 08043624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'Compositions and methods for treatment of microbial infections'
[patent_app_type] => utility
[patent_app_number] => 11/986715
[patent_app_country] => US
[patent_app_date] => 2007-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13022
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/043/08043624.pdf
[firstpage_image] =>[orig_patent_app_number] => 11986715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986715 | Compositions and methods for treatment of microbial infections | Nov 25, 2007 | Issued |